Professor Steven V. Ley Speaks at WuXi PharmaTech

October 7, 2010

SHANGHAI, Oct. 7 /PRNewswire-Asia/ — WuXi PharmaTech (NYSE: WX), a
leading pharmaceutical, biotechnology and medical device research and
development outsourcing company with operations in China and the United States,
is proud to announce that Dr. Steven V. Ley, BP Professor of Chemistry at the
University of Cambridge, visited WuXi AppTec facilities in Shanghai on
September 28. He gave a lecture to WuXi scientists titled “New Tools for
Synthesis: Enabling Technologies” as part of the WuXi AppTec Science Seminar

(Logo: http://photos.prnewswire.com/prnh/20040705/CNM002LOGO )

(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )

Dr. Ley is a world-renowned organic chemist. He founded the Ley Group,
which has published extensively on the synthesis of natural products and has
synthesized more than 130 target compounds. Dr. Ley’s work on iron chemistry,
encapsulated reagents, microbial oxidation, spiroketals, and microwave
chemistry has been groundbreaking. He has pioneered the use of immobilized
reagents in multi-step organic synthesis to make compounds in a cleaner and
more effective way. This work now incorporates flow chemistry for multistep
organic synthesis applications. He has devised many practical and useful
protecting groups using acetal chemistry. He has done significant work in the
area of organic catalysis and was one of the inventors of tetrapropylammonium
perruthenate (TPAP), a catalytic oxidant that is now used worldwide and cited

Dr. Ley has published 698 papers to date. His recent awards include the
Paracelsus Prize, the Heinrich Wieland Prize, the Tetrahedron Prize, the
Perkin Prize for Organic Chemistry, the High Throughput Drug Discovery
Methodologies Award, the Prous Institute-Overton and Meyer Award for New
Technologies in Drug Discovery and the Hans Heroff Inhoffen Medal. In 1990 he
was elected to the Royal Society (London) and was President of The Royal
Society of Chemistry from 2000-2002. He was named a Commander of the Order of
the British Empire (CBE) in January 2002.

“It is an honor to speak at WuXi PharmaTech, which provides high-quality
research and development services to the world’s leading life science
companies,” Dr. Ley said. “I was very impressed by WuXi’s comprehensive
training system and the research capabilities of WuXi scientists.”

“We are privileged to have Dr. Ley share his expertise with our
scientists,” commented Dr. Ge Li, Chairman and Chief Executive Officer of WuXi
AppTec. “As we broaden our R&D service scope, our success depends on the
quality of our scientists. Investing in people will continue to be our key

    For more information, please contact:

     Stephanie Liu (for the media)
     Tel:   +86-21-5046-4362
     Email: Stephanie_liu@wuxiapptec.com

     Ronald Aldridge (for investors)
     Tel:   +1-201-585-2048
     Email: Ron_Aldridge@wuxiapptec.com

SOURCE WuXi PharmaTech

Source: newswire

comments powered by Disqus